Europe Botulinum Toxin Market Size & Outlook, 2026-2033
Global Market
Related Markets
Europe botulinum toxin market highlights
- The Europe botulinum toxin market generated a revenue of USD 2,695.5 million in 2025.
- The market is expected to grow at a CAGR of 8.62% from 2026 to 2033.
- In terms of segment, type a was the largest revenue generating product in 2025.
- Type A is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Germany is expected to register the highest CAGR from 2026 to 2033.
Europe data book summary
| Market revenue in 2025 | USD 2,695.5 million |
| Market revenue in 2033 | USD 5,193.5 million |
| Growth rate | 8.62% (CAGR from 2026 to 2033) |
| Largest segment | Type a |
| Fastest growing segment | Type A |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Type B, Type A |
| Key market players worldwide | Ipsen SA, Merz Pharma, US WorldMeds, Galderma Group AG Registered Shares, Evolus Inc, Allergan, Metabiologics, Lanzhou Institute Of Biological Products |
Other key industry trends
- In terms of revenue, Europe region accounted for 20.5% of the global botulinum toxin market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 5,767.2 million by 2033.
The European botulinum toxin market followed North America in terms of revenue share in 2022 and is expected to maintain its position over the forecast period. The market size is justified by the contribution from developed European economies, such as Germany and the UK, which are major contributors to the Europe BoNT market.
Europe is one of the most advanced regions globally with innovative technologies and well-established infrastructure, resulting in better healthcare facilities & patient care. The region is expected to grow at a lucrative rate over the forecast period due to presence of skilled professionals and rise in the geriatric population.
The rising demand for advanced diagnosis and treatment technologies in Europe is another major factor anticipated to propel the market growth. Furthermore, the relatively less stringent medical device approval process in this region is anticipated to boost market growth.
No credit card required*
Publish Date: Jun 30, 2026
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Botulinum Toxin Market Scope
Botulinum Toxin Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Allergan | View profile | 10001+ | Madison, Wisconsin, United States, North America | www.allergan.com |
| Galderma Group AG Registered Shares | View profile | - | Zählerweg 10, Zug, Switzerland, 6300 | www.galderma.com |
| Merz Pharma | View profile | 5001-10000 | Deutsch, Sachsen, Germany, Europe | www.merz.com |
| Ipsen SA | View profile | 5,325 | 65 Quai Georges Gorse, Billancourt Cedex, Boulogne, France, 92100 | www.ipsen.com |
| US WorldMeds | View profile | 51-100 | Louisville, Kentucky, United States, North America | www.usworldmeds.com |
| Evolus Inc | View profile | 279 | 520 Newport Center Drive, Suite 1200, Newport Beach, CA, United States, 92660 | www.evolus.com |
| Metabiologics | View profile | 11-50 | Madison, Wisconsin, United States, North America | www.metabiologics.com/ |
| Lanzhou Institute Of Biological Products | View profile | 11-50 | Lanzhou, Gansu, China, Asia | www.vacmic.com |
Europe Botulinum Toxin Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Botulinum Toxin Market Outlook will help companies and investors design strategic landscapes.
Type A was the largest segment with a revenue share of 106.57% in 2025.
Horizon Databook has segmented the Europe botulinum toxin market based on type b, type a covering the revenue growth of each sub-segment from 2021 to 2033.
The European botulinum toxin market followed North America in terms of revenue share in 2022 and is expected to maintain its position over the forecast period. The market size is justified by the contribution from developed European economies, such as Germany and the UK, which are major contributors to the Europe BoNT market.
Europe is one of the most advanced regions globally with innovative technologies and well-established infrastructure, resulting in better healthcare facilities & patient care. The region is expected to grow at a lucrative rate over the forecast period due to presence of skilled professionals and rise in the geriatric population.
The rising demand for advanced diagnosis and treatment technologies in Europe is another major factor anticipated to propel the market growth. Furthermore, the relatively less stringent medical device approval process in this region is anticipated to boost market growth.
- Europe Botulinum Toxin Market Product Outlook (Revenue, USD Million , 2021-2033)
- Type A
- Type B
- Europe Botulinum Toxin Market Application Outlook (Revenue, USD Million , 2021-2033)
- Therapeutic
- Aesthetic
- Europe Botulinum Toxin Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Hospitals
- Dermatology Clinics
- Spas and Cosmetic Centers
Reasons to subscribe to Botulinum Toxin Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Botulinum Toxin Market Outlook databook
- Our clientele includes a mix of Botulinum Toxin Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe Botulinum Toxin Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Europe Botulinum Toxin Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Europe Botulinum Toxin Market, 2021-2033 (US$M)
Europe botulinum toxin market statistics, by product, 2021-2033 (US$M)
